The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in income, its patent expiration created a deluge of lower-priced alternatives , significantly impacting its position . While specific businesses may try to capitalize on related treatments , the present